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Cell-to-cell signaling peptides play important roles in
neurotransmission, neuromodulation, and hormonal sig-
naling. Signiﬁcant progress has been achieved in qualita-
tive investigations of signaling peptides in the nervous
system using single cell matrix-assisted laser desorption/
ionization mass spectrometry. However, quantitative in-
formation about signaling peptides is difﬁcult to obtain
with this approach because only small amounts of analytes
are available for analysis. Here we describe several
methods for quantitative microanalysis of peptides in
individual Aplysia californica neurons and small pieces
of tissue. Stable isotope labeling with d0- and d4-succinic
anhydride and iTRAQ reagents has been successfully
adopted for relative quantitation of nanoliter volume
samples containing the Aplysia insulin C peptide. Com-
parative analysis of the C peptide release site, the upper
labial nerve, and its synthesis location, the F- and C-
clusters, shows that the release site possesses almost
three times more of this compound. The method of
standard addition permits absolute quantitation of the
physiologically active neuropeptide cerebrin from small
structures, including nerves and neuronal clusters, in the
femtomole range with a limit of detection of 19 fmol. The
simplicity of these methods and the commercial avail-
ability of the reagents allow quantitative measurements
from a variety of small-volume biological samples.
The central nervous system is one of the most chemically,
structurally, and functionally heterogeneous systems in an animal.
Linking neurochemistry and brain function requires an under-
standing of the cell-cell signaling peptides (SPs) used in the brain.
Matrix-assisted laser desorption/ionization (MALDI) mass spec-
trometry (MS) and electrospray ionization (ESI) MS have become
the technologies of choice for qualitative investigations of the
peptide content in a brain sample. Neuropeptidomics, the detailed
investigation of endogenous peptides in the brain and peripheral
nervous system, continues to evolve
1-8 (for reviews, see refs 9
and 10). Optimized sampling, extraction, and data-analysis meth-
ods are now available for following the multistep processing of
prohormones into biologically active peptides.
2,4,5,7,11-13
Although these approaches are more useful for homogeneous
populations of cells, in the nervous system even adjacent neurons
have signiﬁcantly different biochemical proﬁles that include
unique SP complements. The microliter or larger volumes of
nervous tissue used for neuropeptidome studies contain hundreds
of thousands of cells. As the individual neurons comprising pooled
samples can contain unique complements of SPs that are involved
in functionally antagonistic networks, averaging the SP content
from hundreds of thousands of neurons makes understanding the
functional consequences of this neuropeptide complexity difﬁcult.
Furthermore, the increased dynamic range inherent to such
complex mixtures places constraints on analytical measurement
systems. In contrast, interpretation of results is easier when
performing qualitative and quantitative microanalyses of individual
cells or small representative tissue areas. Not only are these
smaller samples chemically simpler, the putative functions of the
detected peptides are not obscured by the other cell contents
present in larger samples.
In systems biology research, with its emphasis on obtaining,
integrating, and interpreting chemical, spatial, and temporal
information, investigation of individual cells has become an
important focus. With the use of mass spectrometric technologies,
tremendous gains in the qualitative measurement of peptides from
individual neurons have been made.
14-19 MALDI, in particular,
has proven valuable in single cell studies by offering high
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Published on Web 08/16/2008sensitivity, low sample consumption, relatively simple sample
preparation, and the ability to investigate small-volume samples
over a broad dynamic range. MS-based investigations have
enabled a range of prohormones and unusual post-translational
modiﬁcations to be characterized in a number of invertebrate
neuronal model systems, most notably in mollusks
2,15,20 and
arthropods.
21,22 Single cell MALDI MS recently has been used to
investigate mammalian cells,
23,24 and several reports have dem-
onstrated the ability to perform MS peptide sequencing using
single cell samples.
25,26
Clearly, obtaining qualitative information on signaling mol-
ecules at the single cell level is relevant to understanding their
function but so also is the acquisition of quantitative information.
For example, we would expect behavioral changes to be inﬂuenced
by neurotransmitter and neuromodulator levels; in point of fact,
we recently reported that serotonin levels in the soma of an
identiﬁed neuron from Pleurobranchaea californica varied quan-
titatively according to the animal’s hunger state.
27 Several mi-
croanalytical methods are available for quantitative single cell
measurements and include, among others, electrophoresis, im-
munohistochemistry, radioisotope labeling, and reverse tran-
scriptase polymerase chain reaction (see refs 28 and 29 for detailed
descriptions of these technologies). Although a number of
approaches for assaying individual cells are available, most are
less suitable for measuring multiple compounds simultaneously.
This is especially true when examining SPs in individual cells
because of the wide range of concentrations, varied physicochem-
ical properties of the peptides, high levels of biochemical and
morphological compartmentalization in cells, and exceptional
complexity of the intracellular and extracellular matrixes. Another
issue is that SPs typically are packed in dense core vesicles, which
must be lysed for quantitative analysis.
Mass spectrometric methods are often used to obtain quantita-
tive or semiquantitative information on a variety of analytes. A
number of elegant MS-based approaches have been demonstrated
in recent years that use in situ, in vitro, and in vivo isotope labeling
of analytes with
15N,
18O, iTRAQ, ICTL, SILAC, MCAT, d0- and
d4-succinic anhydride-, and Ji et al.
30-36 How well do these
approaches work in neuropeptide investigations? The studies by
Desiderio et al.
37 and others
38 detail quantitative measurement
of neuropeptides, as do more recent approaches using a range of
sample sizes, isotope labeling strategies, and mass analyz-
ers.
6,11,13,39-43
However, even though these quantitative peptide measurement
approaches have been well validated, it is uncertain if they may
be suitable for minute-volume samples such as individual subcel-
lular regions, single cells, and small tissue regions. Although
MALDI MS is capable of proﬁling small samples for qualitative
information,
17,18,24,44,45 adding labeling reagents, performing reac-
tions, and mixing control and experimental samples often has
limited the application of stable isotope labeling to many-fold larger
samples.
Here we demonstrate several strategies for MS-based mea-
surements of peptides in single cells and small tissue samples
that provide both semi- and absolute quantitative information, in
this case using individual molluskan neurons from cerebral
ganglion F- and C-clusters and nerves known to produce Aplysia
insulin (AI) and cerebrin prohormones. We previously character-
ized the neuropeptide content and function of these peptides in
these neurons.
46-48 The approaches described here are based on
well-known stable isotope labeling as well as use of the standard
addition method, employed here on a smaller-volume scale than
before. These strategies broaden signiﬁcantly the application of
single cell MALDI MS in neurobiological and physiological
research and can be adapted to other types of cells and other
small-volume analytical samples.
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Animals. Adult Aplysia californica weighing 175-250 g were
obtained from Charles M. Hollahan (Santa Barbara Marine Bio.,
Santa Barbara, CA). Animals were maintained in constantly
circulated, aerated artiﬁcial seawater (Instant Ocean, Aquarium
Systems, Mentor, OH), chilled to 14 °C.
Chemicals. Sigma-Aldrich (St. Louis, MO) was the source for
all chemicals, unless stated otherwise. Cerebrin was custom-
synthesized by Commonwealth Biotechnologies (Richmond, VA).
Peptide calibration standard II (angiotensin II, angiotensin I,
substance P, bombesin, ACTH clip 1-17, ACTH clip 18-39,
somatostatin 28, bradykinin fragment 1-7, renin substrate tetrade-
capeptide porcine) was obtained from Bruker Daltonics (Bremen,
Germany). Acetonitrile (ACN) was obtained from Fisher Scientiﬁc
(Fair Lawn, NJ).
Sample Preparation. Aplysia californica were anesthetized
by injection of a solution containing 390 mM MgCl2 dissolved in
water, equal by mass to one-third of each animal’s body weight,
into the vascular cavity. The cerebral ganglia with adjacent nerves
were surgically dissected and placed in artiﬁcial seawater (ASW)
containing (in mM) 460 NaCl, 10 KCl, 10 CaCl2, 22 MgCl2,2 6
MgSO4, and 10 HEPES (pH 7.7) supplemented with antibiotics
(100 units/mL penicillin G, 100 µg/mL streptomycin, and 100 µg/
mL gentamicin). A 1% protease type IX in ASW-antibiotics solution
treatment for 60-120 min (depending on animal size) at 34 °C
was used to reduce adherence between cells such as glia and
neurons. This treatment also helps to remove connective tissue
surrounding the ganglia and nerves as well as improves the
success of individual neuron isolation. After the protease treat-
ment, the ganglia were washed in ASW and stored in 33% glycerol/
67% ASW (v/v) solution at 14 °C until use. This solution helps to
stabilize cells during storage and neuron isolation. Isolation of
individual neurons and small pieces of tissue was performed
manually under visual control assisted by a Leica MZ 7.5 high-
performance stereomicroscope with a 7.9:1 zoom (Leica Micro-
systems Inc., Bannockburn, IL).
Morphology. To investigate cellular morphology, saturated
concentrations of sulforhodamine dissolved in 506.2 mM KCl and
5 mM HEPES solution (pH 7.6) were pressure-injected into the
neuronal cell body of interest. Next, the cerebral ganglion was
incubated in ASW containing 10 mM probenecid overnight.
49
Embedding the cerebral ganglia in sucrose was performed with
some modiﬁcations as described by Kabotyanski et al.
50 Brieﬂy,
the ganglia were transferred onto a glass coverslip where ASW
was substituted by a sucrose solution (1 M sucrose, 10 mM CaCl2).
After the preparation was dried at room temperature, the neurons
were investigated using a Zeiss Axiovert inverted microscope (Carl
Zeiss, Oberkochen, Germany) coupled with a CCD camera, driven
by the MCID software package (Imaging Research, Ontario,
Canada).
Mass Spectrometry. An Ultraﬂex II matrix-assisted laser
desorption/ionization time-of-ﬂight/time-of-ﬂight (MALDI TOF/
TOF) mass spectrometer controlled with FlexControl software was
employed in this study (Bruker Daltonics). The mass spectra were
visualized and processed using FlexAnalysis software.
MS peptide proﬁling was performed using the following
instrument settings: reﬂector mode, positive voltage polarity,
pulsed ion extraction delay 20 ns, ion source voltage “1” 25 kV,
ion source voltage “2” 21.7 kV, reﬂector voltage “1” 26.3
kV, reﬂector voltage “2” 13.8 kV, reﬂector detection voltage 1.732
kV, sample rate 0.5 GS/s. In iTRAQ experiments performed to
obtain quantitative information, MS/MS peptide sequencing was
employed. The mass spectrometer settings in this case were as
follows: LIFT TOF/TOF mode,
51 positive voltage polarity, sample
rate 0.5 GS/s, reﬂector detector voltage 1.849 kV, ion source
voltage “1” 8 kV; ion source voltage “2”, 7.2 kV; LIFT voltage “1”,
19 kV; LIFT voltage “2”, 3 kV; reﬂector voltage “1” 29.5 kV,
reﬂector voltage “2” 13.8 kV.
MALDI matrix solution consisted of R-cyano-hydroxycinnamic
acid (CHCA) saturated in a 1:1 mixture of ACN/0.1% (v/v)
aqueous triﬂuoroacetic acid (TFA). Mass calibration was per-
formed internally using one or more of the following approaches:
using known endogenous peptides, adding angiotensin I to the
MALDI matrix, and externally by applying Bruker’s Peptide
Calibration Standard II to the target. For those experiments using
angiotensin I, 160 fmol was deposited on a spot for quantitation
of single cells and small pieces of cerebral commissure. The
angiotensin I amount was increased 10-fold when extracts of F-
and C-clusters and upper labial (ULAB) nerves were characterized.
Peptide Extraction and Stable Isotope Labeling. F- and
C-clusters and the ULAB nerves were dissected from a cerebral
ganglion preparation (for description of cerebral ganglion mor-
phology see ref 48 and Figure 1) and separately incubated in 50
µL of extraction media containing 2:2:1 water/methanol/acetic
acid overnight at 4 °C. Unlike larger samples, homogenization
and sonication were not required for efﬁcient analyte extraction.
The extracts were used in stable isotope labeling experiments
where the amino groups, including free peptide N-termini and
lysine residues, were isotopically labeled with d0- or d4-succinic
anhydride. As a result, masses of labeled peptides increased by
100X Da when a light form of succinic anhydride was added, and
by 104X Da when a heavy form was added (X represents the
number of residues labeled). The labeling procedure used is
similar to one described by Che et al.
11 with several modiﬁcations.
Brieﬂy, a 20-µL aliquot of each sample was supplemented with 70
µL of water, 5 µL of 10 mM phosphate buffer (pH 8), and 4 µLo f
1 M NaOH. Either 1 µLo f2Md0- or of d4-succinic anhydride in
dimethyl sulfoxide (DMSO) was added to the mixtures and
allowed to react for 20 min at room temperature. Next, 1 µLo f1
M NaOH was added to the mixture to maintain a pH of ∼9. The
addition of the succinic anhydride solution, the 20-min incubation
period, and the pH adjustment steps were repeated two more
times. Quenching of unreacted compounds was performed using
10 µL of 2.5 M glycine in water. Because several components,
such as high levels of inorganic salts and DMSO, can interfere
with the MALDI measurement, an additional peptide puriﬁcation
step is often required. Therefore, mixtures of 5 µL of labeled ULAB
and 5 µL of labeled F- and C-cluster samples were cleaned with
ZipTip pipet tips packed with 0.6 µLo fC 18 resin (Millipore,
Bedford, MA). Analytes were eluted from the ZipTip pipet tip with
2 µL of CHCA solution onto a prespotted AnchorChip MALDI
(49) Rosen, S. C.; Teyke, T.; Miller, M. W.; Weiss, K. R.; Kupfermann, I.
J. Neurosci. 1991, 11, 3630–3655.
(50) Kabotyanski, E. A.; Baxter, D. A.; Byrne, J. H. J. Neurophysiol. 1998, 79,
605–621.
(51) Suckau, D.; Resemann, A.; Schuerenberg, M.; Hufnagel, P.; Franzen, J.;
Holle, A. Anal. Bioanal. Chem. 2003, 376, 952–965.
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surface reduced sample spreading and therefore increased analyte
concentration, yielding higher quality and more consistent data.
Individual neuron labeling with the iTRAQ reagents multiplex
kit (Applied Biosystems, Foster City, CA) was performed es-
sentially according to the manufacturer’s manual but with several
modiﬁcations to minimize sample handling and to adjust for the
small sample volumes. Individual cerebral ganglion F-cluster top
layer neurons
48 were manually isolated and placed onto an
AnchorChip sample plate at a region that was not covered with
MALDI matrix. Next, ∼150 nL of acidiﬁed methanol was applied
to the cell-containing spot; the small sample size allows for
successful and quick analyte extraction. The dried sample was
reconstituted in ∼100 nL of iTRAQ buffer on the sample plate,
followed by immediate addition of ∼100 nL of iTRAQ stable
isotope labeled reagent, either 117 or 114. The resulting sample
was dried for 2-4 min, forming a viscous spot, and reconstituted
in 500 nL of CHCA solution. A quality check to test the
completeness of the derivatization was performed with MALDI
MS, and then the samples were redissolved, combined, recrystal-
lized, and reanalyzed.
A similar procedure was applied in experiments with d0-SA
and d4-SA labeling of analytes from single CFT neurons. The same
step as above for on-plate peptide extraction was used and either
acidiﬁed methanol or a 0.1% aqueous solution of formic acid
supplemented with 0.01% TFA was employed as an extraction
media. After spot drying, extracted peptides were reconstituted
in a 100 nL solution containing 6 parts water, 1 part triethylamine
and 1.2 parts of 2 M d0-SA or d4-SA, mixed immediately before
use. Then, a 600-nL MALDI matrix solution was applied after a
15 min reaction time. The resulting samples were examined with
MALDI MS to conﬁrm completeness of labeling. For the ﬁnal step,
samples were reconstituted in 800 nL of a 50/50 ACN/water
mixture, and 500 nL of each sample was taken and mixed in pairs
on clean spots on a MALDI sample plate for relative quantitative
measurements. The last two operations have to be done quickly
due to the evaporation of organic solvent. No cleanup of samples
using a solid phase extraction material was performed. The quality
of labeling using both iTRAQ and succinic anhydride was
determined by the disappearance of signals from unlabeled
analytes in the mass spectra.
Absolute Quantitation Using Standard Addition. For
absolute quantitation of peptides in the F- and C-clusters and in
the ULAB nerves, peptides from the cell(s) or tissue were
extracted using the acidiﬁed methanol solution. Several 200-nL
aliquots of a sample were produced and spiked with internal
synthetic standard, the physiologically active peptide cerebrin,
20
at the appropriate concentration. Next, 300-nL aliquots of the ﬁnal
solutions were deposited onto a sample plate and mixed with 300
nL of CHCA solution.
In experiments to achieve absolute quantitation of the cerebrin
in a small region of the cerebral commissure, ∼1/10 of this
structure was dissected and placed onto a sample plate and
covered with 500 nL of CHCA matrix containing the internal
standard angiotensin I. The samples were examined with MALDI
MS to determine the signals produced by endogenous peptides.
Next, the samples were reconstituted with acidiﬁed methanol
containing synthetic cerebrin as an internal calibrant. Repetitive
cycles of MS measurement, reconstitution/addition of the calibrant
and drying, followed by a new MS measurement, allowed the
construction of a calibration curve for quantitative measurement
of cerebrin in the sample. Importantly, to build this calibration
curve, the intensity of the endogenous cerebrin signal detected
in control measurements was subtracted from the total signal
representing endogenous and spiked cerebrin. Also, intensities
of cerebrin and cerebrin sodium adduct peaks were normalized
to the intensities of the internal standard signals and intensity
values summed. The best-ﬁt line through the calibration curve
was used, and the amount of endogenous peptide was determined.
In all cases, standard deviations of the measurements are
presented. For statistical analysis, three or more individual
samples were analyzed and the mean and standard deviation
calculated.
Figure 1. An Aplysia californica cerebral ganglion has a well deﬁned
but complex structural organization. (A) Microphotograph of the
cerebral ganglion, dorsal side, after treatment with protease and
removal of its protective sheath. (B) Schematic of the cerebral
ganglion with the identiﬁed neuronal clusters localized on its dorsal
side labeled by the appropriate nomenclature letter.
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Optimization of Sample Preparation Protocols. To develop
and optimize quantitative MALDI MS approaches, we used several
well-characterized AI- and cerebrin-producing neuronal networks
partially localized in the F- and C-clusters of the cerebral ganglion
as well as in the ULAB nerve and cerebral commissure.
46,48 These
networks have distinct morphological elements that can be
identiﬁed and isolated. The cell bodies of the AI neurons are
located in the F- and C-clusters of the Aplysia cerebral ganglion
(Figure 1). Processes from these neurons form AI-containing
structures in the anterior tentacular (AT) and ULAB nerves,
regions of putative AI secretion into molluscan blood. Interestingly,
the AT nerve structures are signiﬁcantly larger than the ULAB
structures. Cerebrin has a different distribution; the cerebrin-
expressing neurons have their cell bodies predominantly in the
F-cluster and their terminals in the cerebral commissure and
ULAB nerves. As with other neurosecretory cells, AI- and cerebrin-
expressing neurons produce signiﬁcant amounts of intercellular
signaling peptides. Despite the multicellular nature of these
structures, their relative sizes are small (Figure 1), typically,
several tens to hundreds of micrometers across in the longest
direction. For example, the cerebral commissure and ULAB
nerves have well-developed but small-volume neurohemal release
zones that only occupy the surface layers of both structures. These
factors make these peptidergic systems suitable models for single
cell and small tissue microanalysis method development and
optimization.
To verify that the F- and C-clusters, ULAB nerves, and cerebral
commissure have enough peptides to characterize, we compared
the concentrations of a single peptide from each prohormone, the
AI prohormone C -peptide and cerebrin. For relative quantitation
of the C  peptide, we used d0- and d4-succinic anhydride. This
approach is well established and based on succinylation of free
amino groups where modiﬁcation of basic sites with acidic
carboxyl groups occur.
11,52 Each modiﬁcation results in an
increase of peptide molecular mass by 100 Da for d0-SA and 104
Da for d4-SA. MALDI MS proﬁling of the samples revealed that
both peptides, C  and cerebrin, are present in the extracts (Figure
2A). Moreover, several related peptides, C  (1-14) and C  (1-13),
are also observed. MS/MS experiments conﬁrm that these
shortened peptide forms are endogenous and not caused by in-
source decay of C  (Supporting Information Figure 1). These
peptides are likely products of enzymatic degradation of C .
46
Interestingly, the intensity of the cerebrin peak was relatively low
in the ULAB nerve extract compared to the F- and C-cluster
extracts (Figure 2A). However, a direct interpretation of a lower
MALDI peak intensity as a lower amount of cerebrin present in
the ULAB may not be correct, as peak heights can be altered via
signal suppression by other constituents in the sample.
53,54 Indeed,
analysis of the same samples after stable isotope labeling, mixing,
and puriﬁcation using a solid phase extraction approach demon-
strated that the ULAB nerve extract had a higher amount of
cerebrin than did the F- and C-cluster samples, whereas the C 
peptide was more prominent in the F- and C-cluster samples
(Figure 2B). These results are in agreement with prior immuno-
histochemical data where AI immunoreactive ﬁbers are located
(52) Wang, S.; Regnier, F. E. J. Chromatogr., A 2001, 924, 345–357.
(53) Bouschen, W.; Spengler, B. Int. J. Mass Spectrom. 2007, 266, 129–137.
(54) Hillenkamp, F.; Peter-Katalinic ´, J. MALDI MS: A Practical Guide to
Instrumentation, Methods and Application, 1st ed.; Wiley-VCH: Weinheim,
Germany, 2007.
Figure 2. Known SPs can be detected in extracts of F- and C-clusters and ULAB nerves, including cerebrin. The d0- and d4-succinic anhydride
labeling allows the determination of relative quantities of peptides present in different regions of the nervous system. (A) Mass spectra of F- and
C-cluster and ULAB extracts. (B) Mass spectrum of a mix of ULAB nerve extract labeled with d0-SA and an extract of F- and C-clusters labeled
with d4-SA. SCPb: small cardioactive peptide.
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while cerebrin immunoreactivity is predominantly located in the
ULAB.
20,46,48
Although isotope labeling provides relative quantitation, the
majority of methods for absolute quantitation employ a known
amount of synthetic or puriﬁed calibrant that is identical to an
endogenous analyte. In this work, we used synthetic cerebrin.
To minimize the inﬂuence of factors such as analyte signal
suppression, we employed the method of standard addition
(Figure 3), even though this approach is not normally applied to
so small a volume sample. For our physiological samples, many
analytes produced multiple peaks from the molecular ion and ions
of their alkali metal adducts because of the high salt concentra-
tions in these biological tissues (Figure 3A,C). Relative intensities
of the molecular ion, as well as its individual sodium and potassium
adduct signals, varied from sample-to-sample and could not be
directly ﬁt to calibration curves created via external calibration.
Therefore, our approach included internal spiking with synthetic
standard and summation of the intensities of the cerebrin-related
peaks. This produced consistent data. Results of the absolute
quantitation experiments show that F- and C-clusters, on average,
contain 230 fmol of cerebrin (three individual samples measured
in triplicate) whereas ULAB nerves have ∼700 fmol (three
individual samples measured in triplicate). These observations are
in agreement with data obtained on the same samples analyzed
with the d0-SA and d4-SA approach (Figures 2 and 3). Both the
comparison of cerebrin signals in SA-labeled samples (Figure 2B,
far right insert), and analysis of data obtained in the spiking
experiments (Figure 3B,D), demonstrate that the ULAB nerve
has an approximately 3-fold higher cerebrin amount than that
found in the F- and C-clusters.
Relative Quantitation of Signaling Peptides with Single
Cell MALDI MS. Can these methods be downscaled to work with
individual cells? Individual CFT neurons (Figure 4A) are a good
model for optimization of analytical methods focused on studying
endogenous intercellular signaling peptides. These 50-100-µm
diameter cells can be easily recognized by their location in the
top F-cluster cellular layer and white color, as well as their
expression of signiﬁcant amounts of AI.
46 Larger than many
mammalian neurons, their size is approximately the same as some
of the largest neurons in the human nervous system, e.g., the
magnocellular neuroendocrine neurons and some dorsal root
ganglion neurons.
We developed an approach for peptide labeling in single cells
using the succinic anhydride method that comprises only one
labeling step and does not require peptide puriﬁcation after
derivatization (see Supporting Information). However, this ap-
proach produced more than one labeled product for C  peptide.
Both doubly labeled and smaller, triply labeled peaks were
Figure 3. Absolute quantitation using standard addition with cerebrin as the calibrant. (A) Mass spectra of F- and C-cluster extracts spiked
with different amounts of cerebrin noted above each mass spectrum. (B) Sum of areas of the cerebrin molecular ion peak and the areas of its
sodium and potassium adducts from three different F- and C-cluster extracts measured in triplicate. (C) Mass spectra of ULAB nerve extract
spiked with different amounts of cerebrin. (D) Sum of areas of the cerebrin molecular ion peak and the areas of its sodium and potassium
adducts from three different ULAB nerve extracts measured in triplicate. Standard deviations are shown.
7133 Analytical Chemistry, Vol. 80, No. 18, September 15, 2008detected (Supporting Information Figure 2). This situation intro-
duces added complexity to the quantitative analysis process.
Moreover, the presence of multiple peaks from a single analyte
may result in lower signal intensity of the derivatized analytes.
Another concern is that the formation of succinylated amides at
all amine residues of a peptide may reduce the formation of
positive charges and therefore analyte ionization in the positive
mode.
11 To alleviate the issues of multiple labeling of analytes,
we used the commercially available iTRAQ kit for quantitation
via MALDI MS. The iTRAQ kit includes a set of four isobaric
reagents that react with the amine groups of peptides. The iTRAQ
labeling procedure requires only one step, and the resulting mass
spectra of a derivatized sample tends to be less complicated
because differences in stable isotope labeling are revealed only
during MS/MS experiments.
A schematic of the approach used to analyze individual neurons
is shown in Figure 4B. There are several important steps to ensure
optimal results. The extraction of endogenous peptides should
use an appropriate buffer that is compatible both with the MALDI
measurement process as well as with stable isotope labeling; a
volatile extraction media works well. We used acidiﬁed methanol
because it is known to efﬁciently extract peptides localized in
biological tissues,
55 its higher viscosity allows manipulations of
small solution volumes and deposition in a reasonably small area
without spreading, and it evaporates relatively slowly. In contrast,
we found that the iTRAQ buffer did not work well as an extraction
media for individual neuron samples.
The addition of the standard iTRAQ buffer to samples contain-
ing the extraction buffer resulted in a signiﬁcantly reduced signal
intensity of the labeled peptides. Therefore, improved results were
obtained when the samples were dried after extraction and before
addition of iTRAQ buffer. Surprisingly, direct MS proﬁling shows
that the stable isotope labeling time in such small samples can
be reduced to only several minutes as compared to the manufac-
turer’s recommended1h( F i g u r e4 C ,b ottom two traces). This
reduction in reaction time may be due to (1) small sample sizes
allowing faster mixing, (2) the large excess of labeling reagent,
(3) or the rapid reduction in volume after deposition onto the open
sample plate concentrating analytes and reagents. After the
reaction is complete, the evaporation of volatile solvent leads to
(55) Ma, M.; Kutz-Naber, K. K.; Li, L. Anal. Chem. 2007, 79, 673–681.
Figure 4. iTRAQ labeling allows the determination of relative quantities of peptides present in single neurons. (A) Sample preparation is a
crucial step for successful quantitative MALDI MS measurements of peptides in single cells. Microphotograph of the dorsal view of a F-cluster
with individual cell bodies visible (left). Image of an individual CFT neuron deposited on a MALDI sample plate (right). (B) Steps involved in
peptide quantitation in single neurons using iTRAQ reagents are shown. (C) iTRAQ labeling of peptides in single cell preparations resulted in
formation of singly or doubly labeled molecules. Top mass spectrum represents the peptide proﬁle of an individual CFT neuron before labeling.
Two bottom mass spectra are mixtures of two different pairs of CFT cells. (D) Tandem mass spectra of C  peptide acquired from the mixed
contents of two pairs of individual CFT neurons after separate labeling with iTRAQ 114 and iTRAQ 117. The insets show the mass range
containing isotopic labels cleaved from labeled molecular ions during the fragmentation process. Angiotensin I (m/z 1296) was added as an
internal standard (IS) to the MALDI matrix (top mass spectrum).
7134 Analytical Chemistry, Vol. 80, No. 18, September 15, 2008the formation of a small spot of viscous material, which is then
reconstituted with CHCA solution containing an organic solvent.
Samples were examined with MS before mixing to verify the
absence of detectable amounts of unlabeled analytes, allowing
samples to be mixed without removal of any excess stable isotope
label. Interestingly, labeling with stable isotopes improves the
detectability of several peptides. For example, C  (1-12) is observed
in labeled CFT neurons but not in the unlabeled cell (Figure 4C).
Despite the relatively small amount of analytes in single cells, MS/
MS analysis can be performed on the iTRAQ-labeled peptides. For
example, C  peptides in two different CFT neurons were individually
labeled with the 114 or 117 iTRAQ reagent and subjected to MS/
MS sequencing after sample mixing (Figure 4D). As expected,
samples of two similarly sized and located cells have similar
concentrations of C -peptide (Figure 4D, upper trace), whereas the
second mixture containing a larger and smaller cell (Figure 4D, lower
trace) shows a less intense signal from the smaller cell.
Absolute Quantitation of Signaling Peptides in Small
Tissue Samples with MALDI MS. With the use of MALDI MS,
determination of absolute quantities of cerebrin in small samples,
such as a single cell or commissure subsection, presents several
issues, including the minute analyte amounts and difﬁculties in
small-volume sample handling and manipulation. Dividing samples
into aliquots is not feasible for these nanoliter volume samples
without employing state-of-the-art microﬂuidics.
We validated the well-known approach of standard addition
by consecutive spiking of the sample spot with known peptide
amounts. Although this appears to be a straightforward procedure,
standard addition approaches require a nondestructive readout
because the sample is spiked and the signal measured, and then
an additional aliquot of standard is added and the sample
reanalyzed. Standard addition works here because each MALDI
measurement process uses only a small fraction of the sample.
In essence, most of the analyte is left behind.
56 Additionally,
cerebrin signal intensity was normalized to the signal intensity of
Figure 5. Multiple additions of the calibrant to the same sample spot on the MALDI sample plate allows absolute quantitation of the amount
of analyte present in the spot, in this case, from a small fraction (∼1/10) of the cerebral commissure. (A) Image of the cerebral commissure, a
small structure located between the cerebral hemiganglia containing terminals of cerebrin-expressing neurons. Sulphorhodamine was injected
into the neurons shown on the microphotograph. (B) Procedure used for peptide quantitation. (C) Mass spectra of cerebral commissure sample
repeatedly spiked with cerebrin. (D) Cerebrin amounts measured in ﬁve different pieces of cerebral commissure. 4 represent individual values
for each sample, with the value being the sum of normalized intensities of the cerebrin molecular ion peak and its sodium adduct peak. [ show
average values for increases in the sum of cerebrin and its adduct peak intensities after spiking of the samples with known amounts of cerebrin.
Standard deviations are shown.
7135 Analytical Chemistry, Vol. 80, No. 18, September 15, 2008the internal standard, angiotensin I, which was added with the
MALDI matrix at the ﬁrst preparation step. This normalization
can help to compensate for loss of material if cerebrin and
angiotensin I are consumed during the sample measurement
process. Interestingly, the average intensity of angiotensin I signal
did not change signiﬁcantly over multiple recrystallizations and
spot interrogations (control, 28K counts; 1st recrystallization, 30K
counts; 2nd recrystallization, 30K counts; and 4th recrystallization,
29K counts). At the same time, average intensity of the cerebrin
signal increased during the additions from 200 to 1700 counts.
Therefore, samples previously proﬁled with MALDI MS can be
reconstituted and spiked with an additional amount of calibrant.
Implementation of this strategy allows one to build a complete
calibration curve for a single cell sample to determine the
concentration of peptide; here we have done this for ﬁve individual
small tissue areas containing ∼1/10 of a cerebral commissure
(Figure 5). With the use of a signal-to-noise ratio of 3 as our
detection limit and 10 as the limit of quantitation, the correspond-
ing values were calculated as 19 and 64 fmol. Despite the ability
of this MALDI MS instrument to probe high attomole levels of
peptide standards, the reduced limit of detection observed here
may be because of the high alkali metal concentrations in these
samples or because of their biochemical complexity.
CONCLUSIONS
Successful relative and absolute quantitation of signaling
peptides can be achieved in a single cell-sized sample using
MALDI MS. A combination of appropriate sample preparation
methods, analyte labeling with stable isotope techniques, and
advanced MALDI MS approaches allows relative and absolute
quantitation of analytes in nanoliter volume samples, including
single cells (Table 1). Samples previously analyzed with MALDI
MS can be further modiﬁed by spiking with the analyte of interest,
addition of internal standards, and mixing with other sample(s).
We expect these approaches will be used in a variety of small-
volume investigations, in addition to the neuropeptide application
demonstrated here.
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Table 1. Comparison of Methods Successfully Used in This Study for Peptide Quantiﬁcation in Small Tissue
Samples and Individual Cells Using MALDI MS
approach relative quantitation absolute quantitation single cell analysis complexity of sample prep cost
d0- and d4-succinic anhydride labeling yes no no moderate low
spiking with analyte of interest yes yes easy variable
iTRAQ yes yes easy moderate
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